BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 21719142)

  • 21. CCR4 Expression in Tumor-Infiltrating Regulatory T Cells in Patients with Squamous Cell Carcinoma of the Lung: A Prognostic Factor for Relapse and Survival.
    Asai N; Kubo A; Suzuki S; Murotani K; Numanami H; Yoshikawa K; Ueda R; Yamaguchi E
    Cancer Invest; 2019; 37(3):163-173. PubMed ID: 30907146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors.
    de Reuver PR; Mehta S; Gill P; Andrici J; D'Urso L; Clarkson A; Mittal A; Hugh TJ; Samra JS; Gill AJ
    J Am Coll Surg; 2016 Mar; 222(3):281-7. PubMed ID: 26809747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.
    Zhao S; Jiang T; Zhang L; Yang H; Liu X; Jia Y; Zhou C
    Oncotarget; 2016 Jun; 7(24):36065-36073. PubMed ID: 27153545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma.
    Giatromanolaki A; Banham AH; Harris AL; Koukourakis MI
    Exp Lung Res; 2019; 45(3-4):76-83. PubMed ID: 31134811
    [No Abstract]   [Full Text] [Related]  

  • 26. FOXP3: A Player of Immunogenetic Architecture in Lung Cancer.
    Ziółkowska-Suchanek I; Żurawek M
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
    Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
    Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
    Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
    Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
    Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
    Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
    Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
    Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.
    Kim WY; Jeon YK; Kim TM; Kim JE; Kim YA; Lee SH; Kim DW; Heo DS; Kim CW
    Ann Oncol; 2009 Oct; 20(10):1688-96. PubMed ID: 19542249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection.
    Wang B; Xu D; Yu X; Ding T; Rao H; Zhan Y; Zheng L; Li L
    Ann Surg Oncol; 2011 Sep; 18(9):2585-93. PubMed ID: 21347781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher densities of Foxp3
    Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Beclin-1, an autophagy-related protein, is associated with tumoral FOXP3 expression and Tregs in gastric adenocarcinoma: The function of Beclin-1 expression as a favorable prognostic factor in gastric adenocarcinoma.
    Song MJ; Park S; Won KY
    Pathol Res Pract; 2020 May; 216(5):152927. PubMed ID: 32204925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
    Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
    J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
    Giatromanolaki A; Bates GJ; Koukourakis MI; Sivridis E; Gatter KC; Harris AL; Banham AH
    Gynecol Oncol; 2008 Aug; 110(2):216-21. PubMed ID: 18533240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of FOXP3 expression in triple-negative breast cancer.
    Lee S; Cho EY; Park YH; Ahn JS; Im YH
    Acta Oncol; 2013 Jan; 52(1):73-81. PubMed ID: 23075422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.